By Agence France – Presse published in Rappler
US pharmaceutical giant Pfizer and its German partner BioNTech has applied for an emergency use authorization in the United States for their coronavirus vaccine
The FDA could provide emergency authorization as soon as the first two weeks of December. Read More
